ArticleBlood advances2019

A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis.

Elisabet E Manasanch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.